Nu Skin Enterprises, Inc.
NUS
NYSE·Consumer Defensive·Household & Personal Products·Mkt cap $221.9M
$4.57
▼ -2.56%
P/E
-1.02
Mkt Cap
$221.9M
52-Wk Range
$4.49–$14.62
52-Week Range
$4.49 - $14.62
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 62.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
6 reasons
- Proprietary ageLOC technology platform providing differentiated anti-aging solutions
- Established direct-to-consumer sales model with global distributor network
- Strong brand portfolio (Nu Skin, Pharmanex, ageLOC) with decades of brand equity
- Integrated product ecosystem combining skincare, devices, and supplements for customer loyalty
- Significant R&D capabilities in skincare and nutritional supplement development
- Physical retail presence and service centers in high-growth Mainland China market
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Premium gross margins (69%)
Value
Deep value opportunity - significant discount to Household Products peers
Momentum
Weak
-18.8% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
High yield
5.25% yield
Smart-money signal
Who's buying NUS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 9, 2026
Reported EPS of $0.20 vs $0.20 consensus (0.0% surprise). Revenue of $320.1M vs $345.2M expected (-7.3%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
0.0%
Revenue trend · last 8Q
—
-9%
-13%
-12%
-15%
-17%
-12%
-17%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$430.1M
$445.6M
$364.5M
$386.1M
$364.2M
$370.3M
$320.6M
$320.1M
Margins · last 8Q
Gross
68.2%
Operating
-18.5%
Profit
-78.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How NUS stacks vs Household & Personal Products
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related